May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
The Temporal Sequence of Combined Intravitreal Triamcinolone Acetonide and Photodynamic Therapy for Exudative Age-Related Macular Degeneration
Author Affiliations & Notes
  • K. M. Kulkarni
    Department of Ophthalmology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey
  • D. B. Roth
    Department of Ophthalmology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey
  • W. J. Feuer
    Basom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
  • Footnotes
    Commercial Relationships K.M. Kulkarni, None; D.B. Roth, None; W.J. Feuer, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1789. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. M. Kulkarni, D. B. Roth, W. J. Feuer; The Temporal Sequence of Combined Intravitreal Triamcinolone Acetonide and Photodynamic Therapy for Exudative Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1789. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To compare visual outcomes in patients with exudative age-related macular degeneration (AMD) who were treated with intravitreal triamcinolone acetonide (IVTA) either one week before or on the same day of photodynamic therapy (PDT) with verteporfin.

 
Methods:
 

61 eyes of 60 patients with exudative AMD were treated with IVTA combined with PDT at a single vitreoretinal practice. The 1 Week Prior group consisted of eyes that received IVTA one week prior to PDT. The Same Day group consisted of eyes that received IVTA followed by PDT the same day. No restriction as to the type of CNV (predominantly classic, classic, minimally classic, or occult) or size of the lesion was made. Proportions were compared between the groups with the Chi-square or Fisher's exact test as appropriate. Means were compared with the independent samples t-test, and comparison of the visual results between the two groups after adjusting for important covariates was performed using multiple linear regression.

 
Results:
 

There were 31 eyes in the 1 Week Prior group and 30 eyes in the Same Day group. Twenty-eight of 31 (90.3%) eyes in the 1 Week Prior group and 28 of 30 (93.3%) eyes in the Same Day group completed the 1 year follow-up. There was no statistically significant difference in VA between the groups at baseline, 6-12 week, or 1 year (Table). When the VA outcomes were adjusted for baseline VA, spot size, lesion type, age, and gender, there was no statistical difference in VA between the groups at either 6-12 weeks (P = 0.44) or 1 year (P = 0.28).

 
Conclusions:
 

There appears to be no significant difference in visual outcomes in eyes that receive IVTA one week prior to PDT vs. eyes that receive IVTA and PDT on the same day for the treatment of exudative AMD. Further investigation into the optimal temporal sequence of treatment is required to exclude a difference.  

 
Keywords: age-related macular degeneration • photodynamic therapy • visual acuity 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×